Vaginitis During Pregnancy

  • Larry C. GilstrapIII

Abstract

Vaginitis is a common disorder associated with pregnancy. However, the most common symptom associated with vaginal infection, discharge, is also a common complaint in pregnant women without infection. The normal discharge or leukorrhea encountered during pregnancy is usually white and profuse in nature and is secondary to the marked changes in the hormonal milieu that occur during pregnancy. This increase in vaginal secretion is usually not particularly bothersome to the patient and is of little clinical significance except that it may be confused with vaginal infection or occasionally with rupture of the fetal membranes. Vaginitis, on the other hand, may be quite bothersome to the pregnant patient and is frequently difficult to eradicate; recurrences are common. Moreover, specific therapy may have to be either altered or delayed because of fetal considerations.

Keywords

Tetracycline Candida Cephalosporin Metronidazole Candidiasis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Penza J, Rankin JS: Infectious vaginopathies during pregnancy. Clin Obstet Synecol 13: 223–238, 1970CrossRefGoogle Scholar
  2. 2.
    Catterall RD: Trichomonal infections of the genital tract. Med Clin North Am 56: 1203–1209, 1972PubMedGoogle Scholar
  3. 3.
    Pritchard JA, MacDonald PC: Prenatal care, in Williams Obstetrics, ed 16. New York, Appleton-Century-Crofts, 1980, pp 325–326Google Scholar
  4. 4.
    Fleury FJ: Adult vaginitis. Clin Obstet Gynecol 24: 407–438, 1981PubMedCrossRefGoogle Scholar
  5. 5.
    Gardner HL, Kaufman RH: Candidiasis, in Benign Diseases of the Vulva and Vagina, ed 2. St Louis, CV Mosby, 1981, pp 218–223Google Scholar
  6. 6.
    Lewis JF, O’Brien SM, Ural UM, et al: Corynebacterium vaginale vaginitis in pregnant women. Am J Clin Pathol 56: 580–583, 1971PubMedGoogle Scholar
  7. 7.
    McCormack WM, Hayes CH, Rosner B, et al: Vaginal colonization with Corynebacterium vaginale (Haemophilus vaginalis). J Infect Dis 136: 740–745, 1977PubMedCrossRefGoogle Scholar
  8. 8.
    Oriel JD, Patridge BM, Denny MJ, et al: Genital yeast infections. Br Med J 4: 761–764, 1972PubMedCrossRefGoogle Scholar
  9. 9.
    Eschenbach DA: Vaginal infection. Clin Obstet Gynecol 26: 186–202, 1983PubMedCrossRefGoogle Scholar
  10. 10.
    McLennan MT, Smith JM, McLennan CE: Diagnosis of vaginal mycosis and trichomoniasis: Reliability of cytologic smear, wet smear, and culture. Obstet Gynecol 40: 231–234, 1972PubMedGoogle Scholar
  11. 11.
    Chen KCS, Forsyth PS, Buchanan TM, et al: Amine content of vaginal fluid from untreated patients with nonspecific vaginitis. J Clin Invest 63: 828–835, 1979PubMedCrossRefGoogle Scholar
  12. 12.
    Long WE, Stella JG, Benchakan V: Nystatin, vaginal tablets in treatment of candidal vulvovaginitis. Obstet Gynecol 8: 364–367, 1956Google Scholar
  13. 13.
    Wallenburg HCS, Wladimiroff JW: Recurrence of vulvovaginal candidosis during pregnancy: Comparison of miconazole versus nystatin treatment. Obstet Gynecol 48: 491–494, 1976PubMedGoogle Scholar
  14. 14.
    McNellis D, McLeod M, Lawson J, et al: Treatment of vulvovaginal candidiasis in pregnancy: A comparative study. Obstet Gynecol 50: 674–678, 1977PubMedGoogle Scholar
  15. 15.
    Van Slyke KK, Michel VP, Rein MF: Treatment of vulvovaginal candidiasis with boric acid powder. Am J Obstet Gynecol 141: 145–148, 1981PubMedGoogle Scholar
  16. 16.
    Beard C, Noller K, O’Fallon W, et al: Lack of evidence for cancer due to use of metronidazole. N Engl J Med 301: 519–522, 1979PubMedCrossRefGoogle Scholar
  17. 17.
    Peterson WF, Stauch JE, Ryder CD: Metronidazole in pregnancy. Am J Obstet Gynecol 94: 343–349, 1966Google Scholar
  18. 18.
    Cantu JM, Garcia-Cruz D: Midline facial defects as a teratogenic effect of metronidazole. Birth Defects 18: 84–88, 1982Google Scholar
  19. 19.
    Robinson SC, Mirchandani G: Trichomonas vaginalis V. Further observations on metronidazole (including infant follow-up). Am J Obstet Gynecol 93: 502–505, 1965PubMedGoogle Scholar
  20. 20.
    Morgan I: Metronidazole treatment in pregnancy. Int J Gynecol Obstet 15: 501, 1978Google Scholar
  21. 21.
    Goldman P: Metronidazole: Proven benefits and potential risks. Johns Hopkins Med J 147: 1–9, 1980PubMedGoogle Scholar
  22. 22.
    Pheifer TA, Forsyth PS, Durfee MA, et al: Nonspecific vaginitis: Role of Hemophilus vaginalis and treatment with metonidazole. N Engl J Med 298: 1429–1434, 1978PubMedCrossRefGoogle Scholar
  23. 23.
    Smith RF, Dunkelberg WE: Inhibition of Corynebacterium vaginale by metronidazole. Sex Transm Dis 4: 20–21, 1977PubMedCrossRefGoogle Scholar
  24. 24.
    Schirar A, Rendu C, Vielh JP, et al: Congenital mycosis (Candida albicans),,Biol Neonate 24: 273–288, 1974PubMedGoogle Scholar
  25. 25.
    Delaha EC, Curtin JA, Stevens G, et al: Incidence and significance of Hemophilus vaginalis in nonspecific vaginitis. Am J Obstet Gynecol 89: 996 - 999, 1964PubMedGoogle Scholar
  26. 26.
    Monif GRG, Bear H: Hemophilus (Corynebacterium) vaginalis septicemia. Am J Obstet Gynecol 120: 1041–1045, 1974PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1985

Authors and Affiliations

  • Larry C. GilstrapIII

There are no affiliations available

Personalised recommendations